Literature DB >> 2868883

Somatostatin production by a human medullary thyroid carcinoma cell line.

R F Gagel, W N Palmer, K Leonhart, L Chan, S S Leong.   

Abstract

Somatostatin (SRIF, SRIF-14) is a known product of the normal and malignant parafollicular cell of the thyroid. In this report we characterize SRIF production by the TT cells, a line of transformed calcitonin-producing cells derived from a human medullary thyroid carcinoma. The cells were found to contain (5-12 ng/10(6) cells) and secrete (3-10 ng/10(6) cells X 48 h) immunoreactive SRIF. Molecular sieve chromatography of cell extracts under denaturing conditions showed a major peak with a mol wt slightly larger than 12,700, probably representing pro-SRIF and a second peak which coeluted with SRIF; in one gel chromatogram a very small peak was also noted which coeluted with SRIF-28, but represented less than 0.4% of the total immunoreactive SRIF. Short term secretion of calcitonin and SRIF was stimulated by calcium in vitro (0.5-4 mM) in a dose-related manner. mRNA isolated from the TT cells hybridized to a specific bovine fetal pancreatic SRIF DNA (BFPS-2); there was no hybridization to identical amounts of mRNA from the atT-20/D16, 3T3, or RINC5F cell lines. In vitro translation of the TT cell mRNA followed by immunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the product revealed a single protein band of approximately 13,000 daltons. It was completely abolished when the immunoprecipitation was performed in the presence of excess unlabeled SRIF. Northern transfer of TT cell cytoplasmic RNA and hybridization with FBPS-2 cDNA showed a single hybridizing band with an apparent size of approximately 750 nucleotides. Our observations demonstrate the production of SRIF by a continuous line of human medullary thyroid carcinoma cells and provide a model for studying the biosynthesis and secretion of SRIF in the parafollicular cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868883     DOI: 10.1210/endo-118-4-1643

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Neuroendocrine differentiation in hyalinizing trabecular tumor of the thyroid.

Authors:  Yasuyoshi Shikama; Tadaharu Osawa; Nobuo Yagihashi; Hidekachi Kurotaki; Soroku Yagihashi
Journal:  Virchows Arch       Date:  2003-12       Impact factor: 4.064

2.  Immunocytochemical characterization of two thyroid medullary carcinoma cell lines in vitro.

Authors:  M Zabel; J Seidel; A Kaczmarek; J Surdyk-Zasada; J Grzeszkowiak; A Górny
Journal:  Histochem J       Date:  1995-11

Review 3.  Molecular biology of the regulation of hypothalamic hormones.

Authors:  J M Rondeel; I M Jackson
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

4.  Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.

Authors:  L Mercure; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

5.  Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.

Authors:  Ehrentraud J Eichelbaum; Brian A Vesely; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

6.  Preclinical characterization of tyrosine kinase inhibitor-based targeted therapies for neuroendocrine thyroid cancer.

Authors:  Karine Pozo; Stefan Zahler; Keisuke Ishimatsu; Angela M Carter; Rahul Telange; Chunfeng Tan; Shuaijun Wang; Roswitha Pfragner; Junya Fujimoto; Elizabeth Gardner Grubbs; Masaya Takahashi; Sarah C Oltmann; James A Bibb
Journal:  Oncotarget       Date:  2018-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.